Breakthrough in Plant Disease: New Enzyme Could Lead to Anti-Bacterial Pesticides
Science News – Rebellion Research
Tokyo, Japan – Researchers from Tokyo University of Science have uncovered a pivotal enzyme, XccOpgD, which plays a critical role in the pathogenicity of Xanthomonas bacteria against plants. This groundbreaking discovery opens new avenues for developing targeted pesticides that combat plant diseases without harming beneficial organisms, offering promising prospects for sustainable agriculture.
What is the ranking of Tokyo University of Science?
is Tokyo University of Science good?
Plant diseases pose significant challenges to agricultural productivity, leading to reduced yields and substantial economic losses. Xanthomonas species, notorious plant pathogens, affect key crops like rice, wheat, and tomatoes by suppressing essential plant defense mechanisms using a compound called CβG16α. The newly identified enzyme, XccOpgD, is crucial in synthesizing this compound, enhancing the bacteria’s virulence.
In a study published on June 19, 2024, in the Journal of the American Chemical Society, a research team led by Associate Professor Masahiro Nakajima unveiled the enzyme XccOpgD, a glycoside hydrolase (GH186) found in Xanthomonas campestris pv campestris. The team, including Mr. Sei Motouchi, Principal Scientist Shiro Komba from the Institute of Food Research, NARO, and Hiroyuki Nakai from Niigata University, conducted extensive biochemical analysis to understand the enzyme’s role in CβG16α biosynthesis.
“Glycan structures are intricate and multifaceted, fulfilling diverse crucial roles in nature and organisms. Enzymes synthesize and degrade glycans, exhibiting diverse structures and functions that correspond to glycan diversity. However, our understanding of these enzymes is still limited, which drives the search for new enzymes with varied potentials,” explained Prof. Nakajima.
Using advanced techniques like X-ray crystallography, the team unraveled the catalytic mechanism and substrate specificity of XccOpgD. Unlike previously identified GH186 enzymes, XccOpgD exhibits an unprecedented enzymatic mechanism known as anomer-inverting transglycosylation. This unique structural environment allows the enzyme to synthesize essential sugar chains used by various Gram-negative bacteria for pathogenic purposes.
The discovery revealed that the linear β-1,2-glucan is converted to the cyclic compound CβG16α, crucial for the pathogenicity of Xanthomonas. Structural analysis identified key substrate-binding residues, providing deeper insights into the enzyme’s specific interactions along the glucan chain. Notably, residues D379 and D291 play pivotal roles as catalysts in this process.
“We are expecting a pesticide concept targeting this enzyme homolog in the future. Unlike fungicides that promote the emergence of drug-resistant bacteria in soil, targeting this enzyme could potentially inhibit pathogenicity without causing sterilization. Enzyme homologs identified in this study may serve as promising structure-based drug targets, offering a potential solution to the issue of drug-resistant bacteria,” said Prof. Nakajima.
The discovery of XccOpgD and its role in CβG16α biosynthesis marks a significant advancement in agriculture. It promises to enhance crop resilience and global food security while mitigating the environmental impacts associated with conventional pesticides. This breakthrough offers sustainable solutions to global agricultural challenges, promoting environmental stewardship and economic viability for farmers worldwide.
Reference
Title of original paper: Discovery of Anomer-Inverting Transglycosylase: Cyclic Glucohexadecaose-Producing Enzyme from Xanthomonas, a Phytopathogen
Journal: Journal of the American Chemical Society
DOI: 10.1021/jacs.4c02579
